Why did BIOFILCHEM.BO stock drop pre-market today?

BIOFILCHEM.BO stock fell pre-market due to heavy selling, elevated volume of **24,752**, and pressure from thin margins and stretched receivables. Short-term technical weakness and profit-taking ahead of company updates also amplified the move.

What is the valuation and key metric for BIOFILCHEM.BO stock?

BIOFILCHEM.BO stock trades at **PE 23.65** with EPS **INR 1.75**, price-to-book **3.27**, and market cap near **INR 673,572,582**. These metrics reflect low margins and modest growth expectations.

What does Meyka AI forecast for BIOFILCHEM.BO stock?

Meyka AI's forecast model projects a **yearly price of INR 33.53** for BIOFILCHEM.BO stock, implying **-10.19%** downside versus the current **INR 37.33**. Forecasts are model-based projections and not guarantees.

What are key catalysts investors should watch for BIOFILCHEM.BO stock?

Watch contract manufacturing wins, faster receivables turnover, margin expansion, and quarterly earnings beats. Any corporate update that improves cash flow or reduces days sales outstanding would be a positive catalyst for BIOFILCHEM.BO stock.

IN Stocks

Pre-market: BIOFILCHEM.BO stock down 18.30% to INR 37.33: catalysts to watch

ByHuzaifa Zahoor February 5, 2026February 5, 2026

BIOFILCHEM.BO stock opened sharply lower in pre-market on 06 Feb 2026 at INR 37.33, down 18.30% from the previous close of INR 45.69. Volume is elevated at 24,752 shares versus an average of 7,293, signaling aggressive selling ahead of the session. The move pushes the price toward its 52-week range of INR 28.79–57.98 and re-raises questions on valuation, short-term liquidity and near-term catalysts for Biofil Chemicals and Pharmaceuticals Limited listed on the BSE in India.